Kaina B - Search Results

1

Uptake of glucose-conjugated MGMT inhibitors in cancer cells: role of flippases and type IV P-type ATPases.

Tomaszowski KH, Hellmann N, Ponath V, Takatsu H, Shin HW, Kaina B. Tomaszowski KH, et al. Among authors: kaina b. Sci Rep. 2017 Oct 24;7(1):13925. doi: 10.1038/s41598-017-14129-x. Sci Rep. 2017. PMID: 29066805 Free PMC article.

2

Inactivation of O(6)-methylguanine-DNA methyltransferase by glucose-conjugated inhibitors.

Reinhard J, Eichhorn U, Wiessler M, Kaina B. Reinhard J, et al. Among authors: kaina b. Int J Cancer. 2001 Aug 1;93(3):373-9. doi: 10.1002/ijc.1336. Int J Cancer. 2001. PMID: 11433402

3

Inhibition of O6-methylguanine-DNA methyltransferase by glucose-conjugated inhibitors: comparison with nonconjugated inhibitors and effect on fotemustine and temozolomide-induced cell death.

Kaina B, Mühlhausen U, Piee-Staffa A, Christmann M, Garcia Boy R, Rösch F, Schirrmacher R. Kaina B, et al. J Pharmacol Exp Ther. 2004 Nov;311(2):585-93. doi: 10.1124/jpet.104.071316. Epub 2004 Jul 13. J Pharmacol Exp Ther. 2004. PMID: 15254145

4

Synthesis of 131I-labeled glucose-conjugated inhibitors of O6-methylguanine-DNA methyltransferase (MGMT) and comparison with nonconjugated inhibitors as potential tools for in vivo MGMT imaging.

Mühlhausen U, Schirrmacher R, Piel M, Lecher B, Briegert M, Piee-Staffa A, Kaina B, Rösch F. Mühlhausen U, et al. Among authors: kaina b. J Med Chem. 2006 Jan 12;49(1):263-72. doi: 10.1021/jm050588q. J Med Chem. 2006. PMID: 16392811

5

MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.

Kaina B, Christmann M, Naumann S, Roos WP. Kaina B, et al. DNA Repair (Amst). 2007 Aug 1;6(8):1079-99. doi: 10.1016/j.dnarep.2007.03.008. Epub 2007 May 7. DNA Repair (Amst). 2007. PMID: 17485253 Review.

6

MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome.

Wiewrodt D, Nagel G, Dreimüller N, Hundsberger T, Perneczky A, Kaina B. Wiewrodt D, et al. Among authors: kaina b. Int J Cancer. 2008 Mar 15;122(6):1391-9. doi: 10.1002/ijc.23219. Int J Cancer. 2008. PMID: 18000822

7

Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53.

Naumann SC, Roos WP, Jöst E, Belohlavek C, Lennerz V, Schmidt CW, Christmann M, Kaina B. Naumann SC, et al. Among authors: kaina b. Br J Cancer. 2009 Jan 27;100(2):322-33. doi: 10.1038/sj.bjc.6604856. Epub 2009 Jan 6. Br J Cancer. 2009. PMID: 19127257 Free PMC article.

8

MGMT activity, promoter methylation and immunohistochemistry of pretreatment and recurrent malignant gliomas: a comparative study on astrocytoma and glioblastoma.

Christmann M, Nagel G, Horn S, Krahn U, Wiewrodt D, Sommer C, Kaina B. Christmann M, et al. Among authors: kaina b. Int J Cancer. 2010 Nov 1;127(9):2106-18. doi: 10.1002/ijc.25229. Int J Cancer. 2010. PMID: 20131314

9

Targeting O⁶-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy.

Kaina B, Margison GP, Christmann M. Kaina B, et al. Cell Mol Life Sci. 2010 Nov;67(21):3663-81. doi: 10.1007/s00018-010-0491-7. Epub 2010 Aug 18. Cell Mol Life Sci. 2010. PMID: 20717836 Free PMC article. Review.

10

Intrinsic anticancer drug resistance of malignant melanoma cells is abrogated by IFN-β and valproic acid.

Roos WP, Jöst E, Belohlavek C, Nagel G, Fritz G, Kaina B. Roos WP, et al. Among authors: kaina b. Cancer Res. 2011 Jun 15;71(12):4150-60. doi: 10.1158/0008-5472.CAN-10-3498. Epub 2011 Apr 14. Cancer Res. 2011. PMID: 21493591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters